Tarsus Pharmaceuticals hosted a virtual investor webcast to present their commercialization strategy for TP-03, a potential treatment for Demodex blepharitis.
AI Assistant
TARSUS PHARMACEUTICALS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.